In-field detection and characterization of B/Victoria lineage deletion variant viruses causing early influenza activity and an outbreak in Louisiana, 2019.
Autorzy:
Shu B; Virology, Surveillance and Diagnosis Branch, Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA. Wilson MM; Virology, Surveillance and Diagnosis Branch, Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA. Keller MW; Virology, Surveillance and Diagnosis Branch, Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA. Tran H; Louisiana Department of Health Office of Public Health Laboratory Baton Rouge Louisiana USA. Sokol T; Louisiana Department of Health Office of Public Health, Infectious Disease Epidemiology New Orleans Louisiana USA. Lee G; Louisiana Department of Health Office of Public Health, Infectious Disease Epidemiology New Orleans Louisiana USA. Rambo-Martin BL; Virology, Surveillance and Diagnosis Branch, Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA. Kirby MK; Virology, Surveillance and Diagnosis Branch, Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA. Hassell N; Virology, Surveillance and Diagnosis Branch, Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA. Haydel D; Louisiana Department of Health Office of Public Health Laboratory Baton Rouge Louisiana USA. Hand J; Louisiana Department of Health Office of Public Health, Infectious Disease Epidemiology New Orleans Louisiana USA. WentworthDE; Virology, Surveillance and Diagnosis Branch, Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA. Barnes JR; Virology, Surveillance and Diagnosis Branch, Influenza Division Centers for Disease Control and Prevention Atlanta Georgia USA.
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Jan 05; Vol. 18 (1), pp. e13246. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).
Influenza Activity and Composition of the 2022-23 Influenza Vaccine - United States, 2021-22 Season.
Autorzy:
Merced-Morales A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Daly P; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Abd Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Ajayi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Annan E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Budd A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Colon A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Iuliano AD; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. DaSilva J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Dempster N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Hawkins D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Howa A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Huang S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Kirby M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Kondor R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Liddell J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Moon S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Nguyen HT; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Smith C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Stark T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Tastad K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Ujamaa D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. WentworthDE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kathryn V. Holmes: A Career of Contributions to the Coronavirus Field.
Autorzy:
Bonavia A; Vaccine Development, Bill & Melinda Gates Medical Research Institute, Cambridge, MA 02139, USA. Dominguez SR; Department of Pediatrics-Infectious Diseases, University of Colorado School of Medicine, Aurora, CO 80045, USA. Dveksler G; Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA. Gagneten S; Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA. Howard M; Battelle Memorial Institute, Columbus, OH 43201, USA. Jeffers S; GenSight Biologics, 75012 Paris, France. Qian Z; Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Beijing 100050, China. Smith MK; General Dynamics Information Technology, Falls Church, VA 22030, USA. Thackray LB; Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Tresnan DB; Safety Surveillance and Risk Management, Worldwide Safety, Pfizer, Groton, CT 06340, USA. WentworthDE; COVID-19 Emergency Response, Virology Surveillance and Diagnosis Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329-4027, USA. Wessner DR; Departments of Biology and Public Health, Davidson College, Davidson, NC 28035, USA. Williams RK; NIAID, NIH, Bethesda, MD 20817, USA. Miura TA; Department of Biological Sciences, University of Idaho, Moscow, ID 83844, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Jul 20; Vol. 14 (7). Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:
Biography; Historical Article; Journal Article; Review; Research Support, N.I.H., Extramural
United States Centers for Disease Control and Prevention support for influenza surveillance, 2013-2021.
Autorzy:
McCarron M; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Kondor R; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Zureick K; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Griffin C; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Fuster C; Global Influenza Programme, World Health Organization, Geneva, Switzerland. Hammond A; Global Influenza Programme, World Health Organization, Geneva, Switzerland. Lievre M; Global Influenza Programme, World Health Organization, Geneva, Switzerland. Vandemaele K; Global Influenza Programme, World Health Organization, Geneva, Switzerland. Bresee J; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Xu X; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Dugan VG; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Weatherspoon V; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Williams T; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Vance A; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Fry AM; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Samaan M; Global Influenza Programme, World Health Organization, Geneva, Switzerland. Fitzner J; Global Influenza Programme, World Health Organization, Geneva, Switzerland. Zhang W; Global Influenza Programme, World Health Organization, Geneva, Switzerland. Moen A; Global Influenza Programme, World Health Organization, Geneva, Switzerland. WentworthDE; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America. Azziz-Baumgartner E; Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS A32, Atlanta, GA 30329, United States of America.
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry.
Autorzy:
Wang D; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. . Zhou B; Influenza Division; CDC COVID-19 Emergency Response - Laboratory and Testing Task Force, National Center for Immunization and Respiratory Diseases, Centers For Disease Control and Prevention (CDC), Atlanta, GA, USA. Keppel TR; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Solano M; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Baudys J; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Goldstein J; Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Finn MG; School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, USA. Fan X; Influenza Division; CDC COVID-19 Emergency Response - Laboratory and Testing Task Force, National Center for Immunization and Respiratory Diseases, Centers For Disease Control and Prevention (CDC), Atlanta, GA, USA. Chapman AP; School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, USA. Bundy JL; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Woolfitt AR; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Osman SH; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Pirkle JL; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. WentworthDE; Influenza Division; CDC COVID-19 Emergency Response - Laboratory and Testing Task Force, National Center for Immunization and Respiratory Diseases, Centers For Disease Control and Prevention (CDC), Atlanta, GA, USA. Barr JR; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Dec 07; Vol. 11 (1), pp. 23561. Date of Electronic Publication: 2021 Dec 07.
Re-emergence of influenza virus circulation during 2020 in parts of tropical Asia: Implications for other countries.
Autorzy:
Mott JA; Influenza Division, Centers for Disease Control and Prevention Regional Influenza Program, Bangkok, Thailand. Fry AM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Kondor R; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. WentworthDE; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Olsen SJ; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Amino Acid Substitutions in Positions 385 and 393 of the Hydrophobic Region of VP4 May Be Associated with Rotavirus Attenuation and Cell Culture Adaptation.
Autorzy:
Guo Y; Food Animal Health Research Program, Ohio Agricultural Research and Development Center, Department of Veterinary Preventive Medicine, The Ohio State University, Wooster, OH 44691, USA. WentworthDE; Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. Stucker KM; J. Craig Venter Institute, Rockville, MD 20850, USA. Halpin RA; J. Craig Venter Institute, Rockville, MD 20850, USA. Lam HC; Veterinary Diagnostic Laboratory, University of Minnesota, Saint Paul, MN 55108, USA. Marthaler D; Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA. Saif LJ; Food Animal Health Research Program, Ohio Agricultural Research and Development Center, Department of Veterinary Preventive Medicine, The Ohio State University, Wooster, OH 44691, USA. Vlasova AN; Food Animal Health Research Program, Ohio Agricultural Research and Development Center, Department of Veterinary Preventive Medicine, The Ohio State University, Wooster, OH 44691, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2020 Apr 07; Vol. 12 (4). Date of Electronic Publication: 2020 Apr 07.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
